The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre.

ABSTRACT:

Background

Clinical practice guidelines and re-imbursement schedules vary in the recommended timing of FDG-PET/CT in the diagnostic evaluation of suspected or confirmed lung cancer. The aim was to estimate the probability of requiring more than one invasive test to complete diagnosis and staging in non-small cell lung cancer if FDG-PET/CT was used prior to initial biopsy (FDG-PET/CT First) compared to current Australian funding criteria (CT First).

Methods

Single-centre retrospective study of individuals with pathologically confirmed NSCLC without evidence of metastatic disease on baseline computed tomography (CT) of the chest. Decision tree analysis based on diagnosis and staging approaches estimated the probability of requiring more than one invasive biopsy. A Monte Carlo

SUBMITTER: Johnson A 

PROVIDER: S-EPMC8252249 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature